432 related articles for article (PubMed ID: 17073635)
1. Current pharmacological treatment of nonalcoholic fatty liver.
Portincasa P; Grattagliano I; Palmieri VO; Palasciano G
Curr Med Chem; 2006; 13(24):2889-900. PubMed ID: 17073635
[TBL] [Abstract][Full Text] [Related]
2. Current pharmacological therapies for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
Takahashi Y; Sugimoto K; Inui H; Fukusato T
World J Gastroenterol; 2015 Apr; 21(13):3777-85. PubMed ID: 25852263
[TBL] [Abstract][Full Text] [Related]
3. [Nonalcoholic steatohepatitis: pathogenesis and treatment].
Park SH
Korean J Hepatol; 2008 Mar; 14(1):12-27. PubMed ID: 18367854
[TBL] [Abstract][Full Text] [Related]
4. Antioxidant therapy and drugs interfering with lipid metabolism: could they be effective in NAFLD patients?
Musso G; Anty R; Petta S
Curr Pharm Des; 2013; 19(29):5297-313. PubMed ID: 23394094
[TBL] [Abstract][Full Text] [Related]
5. Nonalcoholic fatty liver disease and lipids.
Wierzbicki AS; Oben J
Curr Opin Lipidol; 2012 Aug; 23(4):345-52. PubMed ID: 22617751
[TBL] [Abstract][Full Text] [Related]
6. Managing nonalcoholic fatty liver disease: recommendations for family physicians.
Grattagliano I; Portincasa P; Palmieri VO; Palasciano G
Can Fam Physician; 2007 May; 53(5):857-63. PubMed ID: 17872748
[TBL] [Abstract][Full Text] [Related]
7. Challenges and Management of Liver Cirrhosis: Practical Issues in the Therapy of Patients with Cirrhosis due to NAFLD and NASH.
Traussnigg S; Kienbacher C; Halilbasic E; Rechling C; Kazemi-Shirazi L; Hofer H; Munda P; Trauner M
Dig Dis; 2015; 33(4):598-607. PubMed ID: 26159280
[TBL] [Abstract][Full Text] [Related]
8. Insulin sensitizers in nonalcoholic fatty liver disease and steatohepatitis: Current status.
Stein LL; Dong MH; Loomba R
Adv Ther; 2009 Oct; 26(10):893-907. PubMed ID: 19921118
[TBL] [Abstract][Full Text] [Related]
9. Nonalcoholic fatty liver disease: current and potential therapies.
Ibrahim MA; Kelleni M; Geddawy A
Life Sci; 2013 Feb; 92(2):114-8. PubMed ID: 23159641
[TBL] [Abstract][Full Text] [Related]
10. Nonalcoholic fatty liver disease: from steatosis to cirrhosis.
Farrell GC; Larter CZ
Hepatology; 2006 Feb; 43(2 Suppl 1):S99-S112. PubMed ID: 16447287
[TBL] [Abstract][Full Text] [Related]
11. Current treatment strategies for non-alcoholic fatty liver disease (NAFLD).
Mishra P; Younossi ZM
Curr Drug Discov Technol; 2007 Aug; 4(2):133-40. PubMed ID: 17691915
[TBL] [Abstract][Full Text] [Related]
12. The treatment of NAFLD.
Trappoliere M; Tuccillo C; Federico A; Di Leva A; Niosi M; D'Alessio C; Capasso R; Coppola F; Dauria M; Loguercio C
Eur Rev Med Pharmacol Sci; 2005; 9(5):299-304. PubMed ID: 16231594
[TBL] [Abstract][Full Text] [Related]
13. Nonalcoholic steatohepatitis and the metabolic syndrome.
Jiang J; Torok N
Metab Syndr Relat Disord; 2008 Mar; 6(1):1-7. PubMed ID: 18370830
[TBL] [Abstract][Full Text] [Related]
14. Nonalcoholic fatty liver disease: pathogenesis and the role of antioxidants.
Mehta K; Van Thiel DH; Shah N; Mobarhan S
Nutr Rev; 2002 Sep; 60(9):289-93. PubMed ID: 12296456
[TBL] [Abstract][Full Text] [Related]
15. Rosiglitazone attenuates age- and diet-associated nonalcoholic steatohepatitis in male low-density lipoprotein receptor knockout mice.
Gupte AA; Liu JZ; Ren Y; Minze LJ; Wiles JR; Collins AR; Lyon CJ; Pratico D; Finegold MJ; Wong ST; Webb P; Baxter JD; Moore DD; Hsueh WA
Hepatology; 2010 Dec; 52(6):2001-11. PubMed ID: 20938947
[TBL] [Abstract][Full Text] [Related]
16. Advances in the understanding and treatment of nonalcoholic fatty liver disease.
Harrison SA; Di Bisceglie AM
Drugs; 2003; 63(22):2379-94. PubMed ID: 14609346
[TBL] [Abstract][Full Text] [Related]
17. Pathophysiology of nonalcoholic steatohepatitis.
McCullough AJ
J Clin Gastroenterol; 2006 Mar; 40 Suppl 1():S17-29. PubMed ID: 16540762
[TBL] [Abstract][Full Text] [Related]
18. Obesity and fatty liver are 'grease' for the machinery of hepatic fibrosis.
Bosserhoff A; Hellerbrand C
Dig Dis; 2011; 29(4):377-83. PubMed ID: 21894008
[TBL] [Abstract][Full Text] [Related]
19. Nonalcoholic fatty liver disease.
Yu AS; Keeffe EB
Rev Gastroenterol Disord; 2002; 2(1):11-9. PubMed ID: 12122975
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial Adaptation in Nonalcoholic Fatty Liver Disease: Novel Mechanisms and Treatment Strategies.
Sunny NE; Bril F; Cusi K
Trends Endocrinol Metab; 2017 Apr; 28(4):250-260. PubMed ID: 27986466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
